A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
NCT05590416
·
clinicaltrials.gov ↗
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Vogt-Koyanagi-Harada Disease
Adalimumab
Interventions
DRUG:
Adalimumab
Sponsor
Tianjin Medical University